Generic Name: tocilizumab

This medication has been identified as Actemra 162 mg/0.9 mL ACTPen® autoinjector. It is supplied by Genentech, Inc.

Actemra is used in the treatment of Giant Cell Arteritis; COVID-19; Systemic Sclerosis-Associated Interstitial Lung Disease; Cytokine Release Syndrome; Juvenile Idiopathic Arthritis and belongs to the drug class interleukin inhibitors. Risk cannot be ruled out during pregnancy. Actemra 162 mg/0.9 mL ACTPen® autoinjector is not a controlled substance under the Controlled Substances Act (CSA).